Particle.news
Download on the App Store

Neuralink Targets 2026 for Mass Brain‑Chip Production, Near‑Fully Automated Implant Surgery

The scale‑up plan follows FDA trial authorization after a $650 million raise bolstered manufacturing ambitions.

Overview

  • Elon Musk said the 2026 implant procedure is expected to be almost entirely automated, with device threads inserted through the dura without removing it.
  • Neuralink reported by September 2025 that 12 people with severe paralysis had received implants and were actively using them, with early users controlling games and web browsing by thought.
  • The company says its clinical work now includes procedures in Canada, and a UK participant was able to control a computer shortly after surgery.
  • Neuralink describes a next‑generation surgical robot that inserts electrode threads in about 1.5 seconds per thread and reaches greater depths to support scalable operations.
  • The push toward broader availability is financed by a $650 million Series E at about a $9 billion valuation, alongside ongoing regulatory scrutiny following U.S. trial clearance.